KNF-19474-48485
4 vaccinations
4 coded responses
38 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 770 / TX
- Registered
- 2021-11-08
- Relationship
- Child or adolescent in my care
- Guardian
- AHN-10581-33065
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-08
Registered in v-safe
-
2021-11-08
Dose 1 — Pfizer-BioNTech
- 2021-11-08
- 2021-11-11
- 2021-11-12
- 2021-11-14
- 2021-11-15
- 2021-11-22
-
2021-11-29
Dose 2 — Pfizer-BioNTech
- 2021-11-29
-
2021-11-30
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · NoneAdult check-in
-
2021-12-01
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2021-12-02
- 2021-12-04
- 2021-12-05
- 2021-12-07
- 2021-12-13
- 2021-12-20
- 2021-12-27
- 2022-01-03
- 2022-01-10
- 2022-02-28
-
2022-05-20
Dose 3 — Pfizer-BioNTech
- 2022-05-28
- 2022-06-03
- 2022-06-10
- 2022-06-17
- 2022-06-24
- 2022-07-01
-
2022-08-19
Survey response — 3 months, dose 3, dependentMedDRA: Malaise, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Fever, malaise, congestion COVID test negativeMedDRA releases: 2024-11 · check-in free text available
-
2022-10-29
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-30
-
2022-10-31
Health check-in — days 1–6 daily, dose 4, dependentFeeling: Good · Site: Redness · NoneAdult check-in
- 2022-11-01
- 2022-11-02
- 2022-11-05
-
2022-11-12
Survey response — day 14, dose 4, dependentMedDRA: Genital infection fungal, Oral herpes, Respiratory tract congestion — Feeling: FairFree text: Cold sores on lips and face. Genital fungal infection. Congestion.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-19
Survey response — day 21, dose 4, dependentMedDRA: Epistaxis, Genital infection fungal, Lymphadenopathy, Nasal dryness, Oral herpes — Feeling: FairFree text: Continued cold sores, swollen lymph nodes, bloody dry nose, genital fungal infection, we have been treating all for a week!MedDRA releases: 2024-11 · check-in free text available
- 2022-11-26
- 2022-12-03
- 2022-12-10
-
2023-01-28
Survey response — 3 months, dose 4, dependentMedDRA: Diarrhoea, Malaise, Vomiting — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
- 2023-04-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-08 | Pfizer-BioNTech | No |
| 2 | 2021-11-29 | Pfizer-BioNTech | No |
| 3 | 2022-05-20 | Pfizer-BioNTech | No |
| 4 | 2022-10-29 | Pfizer-BioNTech | Flu |
Free text
Release 12 — 3 months, dose 3, dependent
Symptoms: Fever, malaise, congestion COVID test negative
Release 12 — day 14, dose 4, dependent
Symptoms: Cold sores on lips and face. Genital fungal infection. Congestion.
Release 12 — day 21, dose 4, dependent
Symptoms: Continued cold sores, swollen lymph nodes, bloody dry nose, genital fungal infection, we have been treating all for a week!
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Diarrhoea | · | · | ✓ |
| SD | Epistaxis | · | · | ✓ |
| SD | Genital infection fungal | · | · | ✓ |
| SD | Lymphadenopathy | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Nasal dryness | · | · | ✓ |
| SD | Oral herpes | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release